InvestorsHub Logo
Followers 1477
Posts 89318
Boards Moderated 1
Alias Born 06/16/2008

Re: None

Saturday, 10/10/2009 12:46:58 PM

Saturday, October 10, 2009 12:46:58 PM

Post# of 58465
Here is a few paragraphs that many of you will appreciate.

This one is from this pr

April 28th, 2009
Genta Announces Allowance of Two Key European Patents for Genasense®


Genta's patent estate related to Genasense is extensive, we have detailed plans for securing rapid approval in Europe with positive data this Fall," said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "The majority of patients enrolled into the AGENDA trial, a Phase 3 trial of Genasense in melanoma that completed accrual earlier this month, originated from Europe. The extended market protection offered by these patents comes at an especially favorable time in the product's lifecycle."

Key words Detailed Plans for Securing & RAPID APPROVAL in EUROPE. Folks way before we get FDA aprroval we will be STEAMROLLING through Europe :)

All the Anwsers are right in front of us.


Here is something else that is big. Possible partner ship with Schering Plough, Who hit a 52wk high yesterday

June 3rd, 2009
Genasense® Combined with Temodar® and Abraxane® Shows Preliminary Evidence of High Response Rates and Extended Survival in Patients with Advanced Melanoma



Based on preclinical evidence of synergy, Genasense was combined with temozolomide (Temodar®; Schering Plough, Inc.), the most commonly used anticancer drug for melanoma, plus ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) [albumen bound]; Abraxis Bioscience, Inc.).


To date, 7 patients (39%) have achieved major objective responses: one with complete response (CR) after 6 cycles of treatment, and 6 with at least a partial response after a minimum of 2 treatment cycles. Five patients have maintained stable disease (SD) after at least 3 treatment cycles (24 weeks), for an overall disease control rate (CR+PR+SD) of 68%. The most commonly observed side-effects were similar to those associated with the chemotherapy drugs used alone, including leukopenia, thrombocytopenia, neuropathy, and hair loss.

The main thing to look at here is NO ADDITIONAL SIDE EFFECTS, Just the Standard reg CHEMO side effects

I may sound like Gary here, But it looks like the DRUG WORKS LOL

Have a great afternoon

Best Regards Smitter .... :)







Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.